Depression Cured Before Our Eyes - Dr. Owen Muir and His Patient, Mia

Name: Depression Cured Before Our Eyes - Dr. Owen Muir and His Patient, Mia
Uploaded: 2026-08-28T03:00:49-07:00
Duration: 1 h 6 min 31 s
Channel: Soft White Underbelly
Description: This video documents a rapid-acting TMS treatment protocol for severe depression, featuring patient Mia Mueller and Dr. Owen Scott Mueller. It highlights…

Soft White Underbelly

01:06:31 Summary & quotes Report Issue

Loading transcript... Click for full transcript

About this episode This video documents a rapid-acting TMS treatment protocol for severe depression, featuring patient Mia Muelle… AI summary

This video documents a rapid-acting TMS treatment protocol for severe depression, featuring patient Mia Mueller and Dr. Owen Scott Mueller. It highlights how a modified, seizure-safe TMS protocol combined with dextroamphetamine allowed for a one-day treatment course that successfully reversed acute suicidal ideation and restored cognitive function. The discussion also covers the barriers to insurance coverage, the role of AI in predicting treatment response, and the potential for future implantable or at-home TMS devices.

Key takeaways 6

Modified TMS Protocol for Seizure History: Standard rapid TMS targets the front of the brain (which can induce seizures in epileptic patients). Dr. Mueller adapted the protocol to target the posterior parietal cortex (Pz) using an inhibitory 3Hz frequency, which prevents seizures while maintaining efficacy.
Dextroamphetamine Adjunct: The treatment includes a single dose of dextroamphetamine (an ancient antibiotic/antidepressant) to increase neuroplasticity, allowing the brain to change more rapidly during the 20 TMS sessions.
Treatment Adherence vs. Medication: One-day TMS has near 100% adherence because the patient is present for the entire treatment, whereas oral medication adherence is often around 60% (or 26% in complex cases like post-transplant), making rapid treatments logistically superior for ensuring care delivery.
AI and Vocal Biomarkers: Companies like Siren are using AI to analyze vocal biomarkers (pauses in speech) with 79% sensitivity and specificity to predict TMS response before treatment begins.
Insurance and Coding Barriers: The primary barrier to widespread TMS adoption is not efficacy but lack of specific Current Procedural Terminology (CPT) codes for accelerated protocols, causing insurance denials despite clinical evidence. Providers often have to submit claims knowing they won't be paid immediately.
Depression as a Mechanical Issue: The speakers frame depression not as a character flaw but as a mechanical issue requiring 'tuning,' comparing it to a guitar string slipping or a diabetic needing insulin, removing the stigma of needing maintenance treatments.

Notable quotes 5 AI-generated: wording and quote attribution may be wrong. Use the play link to verify.

“My light had turned back on. And it wasn't dark anymore. My light had turned back on. And I was noticing the green in a plants, the light coming from a window.”

▶ 23:06 Mia describing the moment during her 17th-19th treatment when her depression lifted and she regained her ability to perceive her surroundings.
“TMS didn't fix my problems, but it showed me a new way. It gave me the ability to look at things differently.”

▶ 34:31 Mia explaining that TMS provided the cognitive capacity to process trauma and emotions, rather than just erasing them.
“It's like this is like dealing with trauma without ever having to talk about it.”

▶ 53:14 Mia reflecting on the benefit of TMS for those who may not want or be able to engage in traditional talk therapy for their trauma.
“Some of what we're doing to solve the problem is working on using artificial intelligence um with listening to the sound of your voice. So vocal biomarkers... we can predict in advance just by listening to two minutes of your voice at the beginning if you're going to have the response Mia had or not based on the pauses in your voice is the most important factor.”

▶ 43:43 Dr. Mueller discussing emerging technology for predicting treatment outcomes.
“There are people who get this like you would recommend uh there's a patient you saw who I know that you you recommended like weekly, right? ... I have one patient who gets TMS every other week um for about a year now.”

▶ 46:21 Discussion showing that TMS durability varies and some patients require frequent maintenance, similar to chronic disease management.